InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Doyle Ramona, Directeur Médical. Insider active across 1 company, notably Recursion Pharmaceuticals, INC.. Aggregated, 6 filings have been recorded. History available since 3 January 2022. The latest transaction was disclosed on 16 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Doyle Ramona
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
832 shares@ US$5.672.5% of flowClass A Common StockSEC:0001209191-22-030255:0
9,072 shares@ US$2.4811.2% of flowClass A Common StockSEC:0001209191-22-022310:0
15,625 shares@ US$2.4819.1% of flowClass A Common StockSEC:0001209191-22-014405:0
38,499 shares0Class A Common StockSEC:0001209191-22-007915:0
15,625 shares@ US$2.4819.1% of flowClass A Common StockSEC:0001209191-22-006598:0
40,322 shares@ US$2.4748.2% of flowClass A Common StockSEC:0001209191-22-002062:0
6 of 6 declarations
About Doyle Ramona
Doyle Ramona is Directeur Médical at Recursion Pharmaceuticals, INC. The record contains 6 filings, and the sampled recent filings run from 2022-01-05 to 2022-05-18. The most common transaction nature is Levée d'options, with buy and sell amounts of 0 in the sampled filings.
